Medicare Enrolled
Dr. Tariqshah Syed, M.D.
Cardiovascular Disease · Teaneck, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Syed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Syed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Syed
Dr. Tariqshah Syed is a cardiovascular disease specialist in Teaneck, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Syed performed 1,718 Medicare services across 1,289 unique beneficiaries.
Between the years covered by Open Payments, Dr. Syed received a total of $5,150 from 45 pharmaceutical and/or device companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Syed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 1,718 Medicare services
$5,150 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,718
Medicare services
Bottom 28% in NJ for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,289
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~90 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
425 | $106 | $425 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
339 | $101 | $325 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
199 | $57 | $225 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
126 | $142 | $630 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
119 | $7 | $30 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
116 | $67 | $230 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
87 | $12 | $50 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
61 | $88 | $370 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
45 | $63 | $250 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
42 | $12 | $50 |
| Cardiac catheterization | 41 | $199 | $935 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
36 | $19 | $85 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
25 | $17 | $70 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
23 | $22 | $100 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
17 | $21 | $82 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
17 | $42 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.4% high complexity
7.5% medium
75.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,150
Total received (2018-2024)
Avg $736/year across 7 years
Top 36% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
316
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,150 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$974
2023
$898
2022
$783
2021
$844
2020
$477
2019
$564
2018
$610
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$303
Janssen Pharmaceuticals, Inc
$155
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
Philips North America LLC
$72
LANTHEUS MEDICAL IMAGING, INC.
$64
MEDICOMP INC
$36
AstraZeneca Pharmaceuticals LP
$33
PFIZER INC.
$31
Amgen Inc.
$30
Kiniksa Pharmaceuticals International, plc
$30
CVRx, Inc.
$25
Recor Medical Inc
$25
Boston Scientific Corporation
$20
Impulse Dynamics (USA) Inc.
$20
HEARTFLOW, INC.
$18
iRhythm Technologies, Inc.
$17
Merck Sharp & Dohme LLC
$16
Top 3 companies account for 55.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$799
Medtronic Vascular, Inc.
$612
Novartis Pharmaceuticals Corporation
$530
Amgen Inc.
$305
Boehringer Ingelheim Pharmaceuticals, Inc.
$282
W. L. Gore & Associates, Inc.
$232
AstraZeneca Pharmaceuticals LP
$227
Abbott Laboratories
$223
PFIZER INC.
$201
Merck Sharp & Dohme LLC
$191
E.R. Squibb & Sons, L.L.C.
$159
Boston Scientific Corporation
$100
CVRx, Inc.
$97
iRhythm Technologies, Inc.
$75
HeartFlow, Inc.
$73
Philips North America LLC
$72
ARBOR PHARMACEUTICALS, INC.
$71
Kowa Pharmaceuticals America, Inc.
$68
Amarin Pharma Inc.
$67
LANTHEUS MEDICAL IMAGING, INC.
$64
Bardy Diagnostics, Inc.
$56
Philips Electronics North America Corporation
$47
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$46
Lundbeck LLC
$44
Kiniksa Pharmaceuticals, Ltd.
$43
Merck Sharp & Dohme Corporation
$42
GE HealthCare
$39
MEDICOMP INC
$36
BOSTON SCIENTIFIC CORPORATION
$34
Kiniksa Pharmaceuticals International, plc
$30
Acist Medical Systems, Inc.
$28
Molnlycke Health Care US, LLC
$26
ABIOMED
$26
Recor Medical Inc
$25
ATRICURE, INC.
$23
Impulse Dynamics (USA) Inc.
$20
HEARTFLOW, INC.
$18
Novo Nordisk Inc
$17
SANOFI-AVENTIS U.S. LLC
$16
Medicure Pharma Inc.
$16
PORTOLA PHARMACEUTICALS, INC.
$15
Esperion Therapeutics, Inc.
$15
Gilead Sciences, Inc.
$15
Optinose US, Inc.
$14
LifeWatch Services Inc
$12
Top 3 companies account for 37.7% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5091) Amb Mon & Diag Und · (CK4) MCOT · (CK7) Extended Holter · ATRICLIP LAA EXCLUSION SYSTEM · Arcalyst · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CHANTIX · CVI Systems · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Confirm Rx · CoreValve Evolut · Corlanor · DEFINITY · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · FFRct · GORE CARDIOFORM Septal Occluder · Impella · JARDIANCE · LATITUDE Communicator Power Supply · LEQVIO · LifeVest · Livalo · MULTAQ · Mepilex Border Post-Op · MitraClip System · NEXLETOL · NORTHERA · Optimizer · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · RHYTHMIA · Repatha · Reveal LINQ · TELEPATCH CARDIAC MONITOR · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XIENCE SIERRA · Xhance · Xience cornary stent systems · ZIO XT Patch · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,880
Per 100K population
196.9
County median income
$123,715
Nearest hospital
HOLY NAME MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Syed is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Syed experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Syed performed 425 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Syed receive payments from pharmaceutical companies?
Yes. Dr. Syed received a total of $5,150 from 45 companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Syed's costs compare to other cardiologists in Teaneck?
Dr. Syed's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Syed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Teaneck
Browse cardiologists in Teaneck ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology